Rationale for Combination Therapy of Chronic Myelogenous Leukaemia With Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600242
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC